<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30378208</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1654</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Reviews in medical virology</Title><ISOAbbreviation>Rev Med Virol</ISOAbbreviation></Journal><ArticleTitle>An update on enterovirus 71 infection and interferon type I response.</ArticleTitle><Pagination><StartPage>e2016</StartPage><MedlinePgn>e2016</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2016</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/rmv.2016</ELocationID><Abstract><AbstractText>Enteroviruses are members of Pichornaviridae family consisting of human enterovirus group A, B, C, and D as well as nonhuman enteroviruses. Hand, foot, and mouth disease (HFMD) is a serious disease which is usually seen in the Asia-Pacific region in children. Enterovirus 71 and coxsackievirus A16 are two important viruses responsible for HFMD which are members of group A enterovirus. IFN &#x3b1; and &#x3b2; are two cytokines, which have a major activity in the innate immune system against viral infections. Most of the viruses have some weapons against these cytokines. EV71 has two main proteases called 2A and 3C, which are important for polyprotein processing and virus maturation. Several studies have indicated that they have a significant effect on different cellular pathways such as interferon production and signaling pathway. The aim of this study was to investigate the latest findings about the interaction of 2A and 3C protease of EV71 and IFN production/signaling pathway and their inhibitory effects on this pathway.</AbstractText><CopyrightInformation>&#xa9; 2018 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rasti</LastName><ForeName>Mojtaba</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9622-4839</Identifier><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanbabaei</LastName><ForeName>Hashem</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4442-9605</Identifier><AffiliationInfo><Affiliation>Medical Physics Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teimoori</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9037-7757</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Ahvaz Jundishapur University of Medical Sciences</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rev Med Virol</MedlineTA><NlmUniqueID>9112448</NlmUniqueID><ISSNLinking>1052-9276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="Y">Immune Evasion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2A protease</Keyword><Keyword MajorTopicYN="N">3C protease introduction</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">interferon type I</Keyword></KeywordList><CoiStatement>The authors have no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30378208</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zoll J, Heus HA, van Kuppeveld FJ, Melchers WJ. The structure&#x2013;function relationship of the enterovirus 3&#x2032;&#x2010;UTR. Virus Res. 2009;139(2):209&#x2010;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">18706945</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Fan P, Jin J, et al. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J. 2013;10(1):250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen E&#x2010;R, Hsu K&#x2010;H, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999;341(13):929&#x2010;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y&#x2010;C, Yu C&#x2010;K, Wang Y&#x2010;F, Liu C&#x2010;C, Su I&#x2010;J, Lei H&#x2010;Y. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85(1):69&#x2010;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91&#x2010;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Chee H&#x2010;Y, Al&#x2010;Kobaisi MF, Xiaoshan J, Chua KB, Lam SK. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 1999;61(1):1&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Sam I&#x2010;C, Yusof J, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis. 2009;15(1):79&#x2010;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2660687</ArticleId><ArticleId IdType="pubmed">19116058</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP Jr, Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease&#x2014;United States, 1977&#x2013;1991. J Infect Dis. 1994;169(4):905&#x2010;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert GL, Dickson KE, Waters M, Kennett ML, Land SA, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J. 1988;7(7):484&#x2010;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">2841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehle J, Roth B, Metzger C, Pfitzner A, Enders G. Molecular characterization of an enterovirus 71 causing neurological disease in Germany. J Neurovirol. 2003;9(1):126&#x2010;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">12587076</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75(16):7732&#x2010;7738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236&#x2010;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL&#x2010;1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6(11):e1001174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Han M, Xu L, An D, Kong W, Jiang C. Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells. Virol Sin. 2012;27(4):221&#x2010;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218092</ArticleId><ArticleId IdType="pubmed">22899429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer E, Hellen CU, Cao X. Genetics of poliovirus. Annu Rev Genet. 1993;27(1):353&#x2010;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">8122908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai See Lum L, Chua KB, Mcminn PC, et al. Echovirus 7 associated encephalomyelitis. J Clin Virol. 2002;23:153&#x2010;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde&#x2010;inactivated whole&#x2010;virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 2010;84(1):661&#x2010;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Agol VI. Picornavirus genome: an overview In: Semler B, Wimmer E, eds, Molecular Biology of Picornavirus. Washington, DC: American Society of Microbiology Press; 2002:127&#x2010;148.</Citation></Reference><Reference><Citation>Merkle I, Van Ooij MJ, van Kuppeveld FJ, et al. Biological significance of a human enterovirus B&#x2010;specific RNA element in the 3&#x2032; nontranslated region. J Virol. 2002;76(19):9900&#x2010;9909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136489</ArticleId><ArticleId IdType="pubmed">12208967</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol. 2004;78(20):11097&#x2010;11107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521805</ArticleId><ArticleId IdType="pubmed">15452230</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, et al. Identification of site&#x2010;specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8(7):e1002826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P&#x2010;selectin glycoprotein ligand&#x2010;1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2010;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798&#x2010;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD&#x2010;1 intestinal cells. Virol J. 2009;6(1):141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka A, Yanai H. Interferon signalling network in innate defence. Cell Microbiol. 2006;8(6):907&#x2010;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">16681834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard P, Kindsvogel W, Xu W, et al. IL&#x2010;28, IL&#x2010;29 and their class II cytokine receptor IL&#x2010;28R. Nat Immunol. 2003;4(1):63&#x2010;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">12469119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ji L, Yuan X, Jin Y, Cardona CJ, Xing Z. Differential regulation of TLR signaling on the induction of antiviral interferons in human intestinal epithelial cells infected with enterovirus 71. PLoS One. 2016;11(3):e0152177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805281</ArticleId><ArticleId IdType="pubmed">27007979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816&#x2010;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">16410796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenfusser S, Goutagny N, DiPerna G, et al. The RNA helicase Lgp2 inhibits TLR&#x2010;independent sensing of viral replication by retinoic acid&#x2010;inducible gene&#x2010;I. J Immunol. 2005;175(8):5260&#x2010;5268.</Citation><ArticleIdList><ArticleId IdType="pubmed">16210631</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H&#x2010;box helicases RIG&#x2010;I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005;175(5):2851&#x2010;2858.</Citation><ArticleIdList><ArticleId IdType="pubmed">16116171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatematsu M, Seya T, Matsumoto M. Beyond dsRNA: toll&#x2010;like receptor 3 signalling in RNA&#x2010;induced immune responses. Biochem J. 2014;458(2):195&#x2010;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">24524192</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, McWhirter SM, Faia KL, et al. IKK&#x3b5; and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003;4(5):491&#x2010;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;cker H, Redecke V, Blagoev B, et al. Specificity in toll&#x2010;like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006;439(7073):204&#x2010;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16306937</ArticleId></ArticleIdList></Reference><Reference><Citation>Oganesyan G, Saha SK, Guo B, et al. Critical role of TRAF3 in the toll&#x2010;like receptor&#x2010;dependent and&#x2010;independent antiviral response. Nature. 2006;439(7073):208&#x2010;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">16306936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Grandvaux N, Zhou G&#x2010;P, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK&#x2010;related pathway. Science. 2003;300(5622):1148&#x2010;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">12702806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning S, Pagano J, Barber G. IRF7: activation, regulation, modification and function. Genes Immun. 2011;12(6):399&#x2010;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437765</ArticleId><ArticleId IdType="pubmed">21490621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol. 2013;87(3):1690&#x2010;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, et al. The 3C protein of enterovirus 71 inhibits retinoid acid&#x2010;inducible gene I&#x2010;mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol. 2010;84(16):8051&#x2010;8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Goubau D, Deddouche S, e Sousa CR. Cytosolic sensing of viruses. Immunity. 2013;38(5):855&#x2010;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111113</ArticleId><ArticleId IdType="pubmed">23706667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, Ellegast J, Kim S, et al. 5'&#x2010;Triphosphate RNA is the ligand for RIG&#x2010;I. Science. 2006;314(5801):994&#x2010;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlee M, Roth A, Hornung V, et al. Recognition of 5&#x2032; triphosphate by RIG&#x2010;I helicase requires short blunt double&#x2010;stranded RNA as contained in panhandle of negative&#x2010;strand virus. Immunity. 2009;31(1):25&#x2010;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824854</ArticleId><ArticleId IdType="pubmed">19576794</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Hato SV, Langereis MA, et al. MDA5 detects the double&#x2010;stranded RNA replicative form in picornavirus&#x2010;infected cells. Cell Rep. 2012;2(5):1187&#x2010;1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103987</ArticleId><ArticleId IdType="pubmed">23142662</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Vakakis E, Kar S, Richer E, Evans GL, Triantafilou M. Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses. J Cell Sci. 2012;125:4761&#x2010;4769. 10.1242/jcs.103887</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.103887</ArticleId><ArticleId IdType="pubmed">22797917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Sun M, Yuan X, et al. Enterovirus 71 Suppresses Interferon Responses by Blocking JAK/STAT Signaling through Inducing Karyopherin&#x2010;&#x3b1;1 Degradation. J Biol Chem. 2017;292(24):10262&#x2010;10274. 10.1074/jbc.M116.745729</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.745729</ArticleId><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, San&#xe9; F, Riedweg K, et al. Viruses and type 1 diabetes: focus on the enteroviruses. In Type 1 diabetes. InTech 2013.</Citation></Reference><Reference><Citation>Seipelt J, Guarn&#xe9; A, Bergmann E, et al. The structures of picornaviral proteinases. Virus Res. 1999;62(2):159&#x2010;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">10507325</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Svedin E, Kapell S, Nurminen A, Hyt&#xf6;nen VP, Flodstr&#xf6;m&#x2010;Tullberg M. Enteroviral proteases: structure, host interactions and pathogenicity. Rev Med Virol. 2016;26(4):251&#x2010;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom N, Hansen J, Brunak S, Blaas D. Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci. 1996;5(11):2203&#x2010;2216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2143287</ArticleId><ArticleId IdType="pubmed">8931139</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K&#x2010;F, Li M&#x2010;L, Hung C&#x2010;T, Shih S&#x2010;R. Enterovirus 71 3C protease cleaves a novel target CstF&#x2010;64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5(9):e1000593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Wang Y, Cao L, et al. A conserved inhibitory mechanism of a lycorine derivative against enterovirus and hepatitis C virus. Antimicrob Agents Chemother. 2016;60(2):913&#x2010;924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750679</ArticleId><ArticleId IdType="pubmed">26596952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramajayam R, Tan KP, Liang PH. Recent development of 3C and 3CL protease inhibitors for anti&#x2010;coronavirus and anti&#x2010;picornavirus drug discovery. Biochem Soc Trans. 2011;39(5):1371&#x2010;1375. 10.1042/BST0391371</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0391371</ArticleId><ArticleId IdType="pubmed">21936817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandadapu SR, Weerawarna PM, Prior AM, et al. Macrocyclic inhibitors of 3C and 3C&#x2010;like proteases of picornavirus, norovirus, and coronavirus. Bioorg Med Chem Lett. 2013;23(13):3709&#x2010;3712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3750990</ArticleId><ArticleId IdType="pubmed">23727045</ArticleId></ArticleIdList></Reference><Reference><Citation>Patick AK, Brothers MA, Maldonado F, et al. In vitro antiviral activity and single&#x2010;dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 2005;49(6):2267&#x2010;2275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1140523</ArticleId><ArticleId IdType="pubmed">15917520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden FG, Turner RB, Gwaltney JM, et al. Phase II, randomized, double&#x2010;blind, placebo&#x2010;controlled studies of ruprintrivir nasal spray 2&#x2010;percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother. 2003;47(12):3907&#x2010;3916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296196</ArticleId><ArticleId IdType="pubmed">14638501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsyu P&#x2010;H, Pithavala YK, Gersten M, Penning CA, Kerr BM. Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. Antimicrob Agents Chemother. 2002;46(2):392&#x2010;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC127051</ArticleId><ArticleId IdType="pubmed">11796347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Fan T, Yao X, et al. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J Virol. 2011;85(19):10021&#x2010;10030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196404</ArticleId><ArticleId IdType="pubmed">21813612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Song Z, Qin B, et al. Rupintrivir is a promising candidate for treating severe cases of enterovirus&#x2010;71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res. 2013;97(3):264&#x2010;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Qi J, Chen Z, et al. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti&#x2010;hand, foot, and mouth disease virus drug design. J Virol. 2011;85(19):10319&#x2010;10331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196414</ArticleId><ArticleId IdType="pubmed">21795339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Meijer A, Froeyen M, et al. Antiviral activity of broad&#x2010;spectrum and enterovirus&#x2010;specific inhibitors against clinical isolates of enterovirus D68. Antimicrob Agents Chemother. 2015;59(12):7782&#x2010;7785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649165</ArticleId><ArticleId IdType="pubmed">26369972</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanias LC. Mechanisms of type&#x2010;I&#x2010;and type&#x2010;II&#x2010;interferon&#x2010;mediated signalling. Nat Rev Immunol. 2005;5(5):375&#x2010;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">15864272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli E&#x2010;K, Schmolke M, Wolff T, et al. Influenza a virus inhibits type I IFN signaling via NF&#x2010;&#x3ba;B&#x2010;dependent induction of SOCS&#x2010;3 expression. PLoS Pathog. 2008;4(11):e1000196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Zhang L, Wu Z, Tien P. Differential interferon pathway gene expression patterns in rhabdomyosarcoma cells during enterovirus 71 or coxsackievirus A16 infection. Biochem Biophys Res Commun. 2014;447(3):550&#x2010;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">24735544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu&#x2010;Martinez NM, Joachims M, Lloyd RE. Efficient cleavage of 12ribosome&#x2010;associated poly (a)&#x2010;binding protein by enterovirus 3C protease. J Virol. 2002;76(5):2062&#x2010;2074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135927</ArticleId><ArticleId IdType="pubmed">11836384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu&#x2010;Martinez NM, Van Eden ME, Younan P, Lloyd RE. Cleavage of poly (a)&#x2010;binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol Cell Biol. 2004;24(4):1779&#x2010;1790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC344173</ArticleId><ArticleId IdType="pubmed">14749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommergruber W, Ahorn H, Klump H, et al. 2A proteinases of coxsackie&#x2010;and rhinovirus cleave peptides derived from eIF&#x2010;4&#x3b3; via a common recognition motif. Virology. 1994;198(2):741&#x2010;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">8291255</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark ME, H&#xe4;mmerle T, Wimmer E, Dasgupta A. Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J. 1991;10(10):2941&#x2010;2947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC453008</ArticleId><ArticleId IdType="pubmed">1915271</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark ME, Lieberman PM, Berk AJ, Dasgupta A. Direct cleavage of human TATA&#x2010;binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol. 1993;13(2):1232&#x2010;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC359008</ArticleId><ArticleId IdType="pubmed">8380894</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk M, Grigera P, Bergmann I, Zibert A, Multhaup G, Beck E. Foot&#x2010;and&#x2010;mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol. 1990;64(2):748&#x2010;756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249169</ArticleId><ArticleId IdType="pubmed">2153239</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidman MK, Yalamanchili P, Ng B, Tsai W, Dasgupta A. Poliovirus 3C protease&#x2010;mediated degradation of transcriptional activator p53 requires a cellular activity. Virology. 2001;291(2):260&#x2010;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">11878895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Datta U, Dasgupta A. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus&#x2010;encoded protease 3Cpro. J Virol. 1997;71(2):1220&#x2010;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191176</ArticleId><ArticleId IdType="pubmed">8995645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Weidman K, Dasgupta A. Cleavage of transcriptional activator Oct&#x2010;1 by poliovirus encoded protease 3Cpro. Virology. 1997;239(1):176&#x2010;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">9426457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaariainen L, Ranki M. Inhibition of cell functions by RNA&#x2010;virus infections. Annu Rev Microbiol. 1984;38(1):91&#x2010;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">6093688</ArticleId></ArticleIdList></Reference><Reference><Citation>Amineva S, Aminev A, Palmenberg A, Gern J. Rhinovirus 3C protease precursors 3CD and 3CD&#x2032; localize to the nuclei of infected cells. J Gen Virol. 2004;85(10):2969&#x2010;2979.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Raychaudhuri S, Dasgupta A. Nuclear entry of poliovirus protease&#x2010;polymerase precursor 3CD: implications for host cell transcription shut&#x2010;off. Virology. 2004;320(2):195&#x2010;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Hyman L, Moore C. Formation of mRNA 3&#x2032; ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev. 1999;63(2):405&#x2010;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC98971</ArticleId><ArticleId IdType="pubmed">10357856</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M&#x2010;L, Hsu T&#x2010;A, Chen T&#x2010;C, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293(2):386&#x2010;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7(2):131&#x2010;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Takahashi K, Sato S, et al. IPS&#x2010;1, an adaptor triggering RIG&#x2010;I&#x2010;and Mda5&#x2010;mediated type I interferon induction. Nat Immunol. 2005;6(10):981&#x2010;988.</Citation><ArticleIdList><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Yao Y, Chen Y, et al. Enterovirus 71 3C promotes apoptosis through cleavage of PinX1, a telomere binding protein. J Virol. 2017;91:e02016&#x2010;e02016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215332</ArticleId><ArticleId IdType="pubmed">27847364</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Lei X, Zhou Z, et al. Enterovirus 71 induces degradation of TRIM38, a potential E3 ubiquitin ligase. Virol J. 2011;8(1):61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3048563</ArticleId><ArticleId IdType="pubmed">21306652</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Hu Y, Li J, et al. Suppression of the toll&#x2010;like receptor 7&#x2010;dependent type i interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication. Arch Virol. 2018;163(1):135&#x2010;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5756282</ArticleId><ArticleId IdType="pubmed">29052054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Wang B, Huang H, et al. Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum&#x2010;associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD component p97 to promote its replication. PLoS Pathog. 2017;13(10):e1006674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650186</ArticleId><ArticleId IdType="pubmed">28985237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Han N, Xiao X, Jin Q, He B, Wang J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J Virol. 2014;88(17):9830&#x2010;9841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KE, Mossman KL. Recent advances in understanding viral evasion of type I interferon. Immunology. 2013;138(3):190&#x2010;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573272</ArticleId><ArticleId IdType="pubmed">23173987</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti&#x2010;viral type I interferon responses. PLoS Pathog. 2013;9(3):e1003231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Morrison JM, Drahos J, et al. MDA&#x2010;5 is cleaved in poliovirus&#x2010;infected cells. J Virol. 2007;81(8):3677&#x2010;3684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. RIG&#x2010;I is cleaved during picornavirus infection. Virology. 2009;391(2):171&#x2010;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Papon L, Oteiza A, Imaizumi T, et al. The viral RNA recognition sensor RIG&#x2010;I is degraded during encephalomyocarditis virus (EMCV) infection. Virology. 2009;393(2):311&#x2010;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">19733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Li X, Li P, et al. Enterovirus 71 inhibits cellular type I interferon signaling by inhibiting host RIG&#x2010;I ubiquitination. Microb Pathog. 2016;100:84&#x2010;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">27633794</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol. 2014;88(6):3369&#x2010;3378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R&#x2010;L, Kao L&#x2010;T, Lin S&#x2010;J, Wang RY&#x2010;L, Shih S&#x2010;R. MDA5 plays a crucial role in enterovirus 71 RNA&#x2010;mediated IRF3 activation. PLoS One. 2013;8(5):e63431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Drahos J, Racaniello VR. Cleavage of IPS&#x2010;1 in cells infected with human rhinovirus. J Virol. 2009;83(22):11581&#x2010;11587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772720</ArticleId><ArticleId IdType="pubmed">19740998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Morosky SA, Delorme&#x2010;Axford E, et al. The coxsackievirus B 3Cpro protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011;7(3):e1001311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86(7):3767&#x2010;3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang Z, Zhao X, et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 2014;27(6):267&#x2010;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H&#x2010;C, Wang H&#x2010;C, Shih S&#x2010;R, Teng I&#x2010;F, Tseng C&#x2010;P, Hsu JT&#x2010;A. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis. 2011;203(12):1784&#x2010;1790.</Citation><ArticleIdList><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Sun M, Yuan X, et al. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin&#x2010;&#x3b1;1 degradation. J Biol Chem. 2017;292(24):10262&#x2010;10274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride KM, Banninger G, McDonald C, Reich NC. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin&#x2010;&#x3b1;. EMBO J. 2002;21(7):1754&#x2010;1763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125956</ArticleId><ArticleId IdType="pubmed">11927559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chook Y, Blobel G. Karyopherins and nuclear import. Curr Opin Struct Biol. 2001;11(6):703&#x2010;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">11751052</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Bi J, Liu J, et al. 3Cpro of FMDV antagonizes IFN signaling pathway by blocking STAT1/STAT2 nuclear translocation. J Virol. 2014;88(9):4908&#x2010;4920. 10.1128/JVI.03668-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03668-13</ArticleId><ArticleId IdType="pmc">PMC3993825</ArticleId><ArticleId IdType="pubmed">24554650</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung LW, Hartman AL, Martinez O, et al. Ebola virus VP24 binds karyopherin &#x3b1;1 and blocks STAT1 nuclear accumulation. J Virol. 2006;80:5156&#x2010;5167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472181</ArticleId><ArticleId IdType="pubmed">16698996</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Edwards MR, Borek DM, et al. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe. 2014;16(2):187&#x2010;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4188415</ArticleId><ArticleId IdType="pubmed">25121748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Nan Y, Yu Y, Zhang Y&#x2010;J. Porcine reproductive and respiratory syndrome virus Nsp1&#x3b2; inhibits interferon&#x2010;activated JAK/STAT signal transduction by inducing karyopherin&#x2010;&#x3b1;1 degradation. J Virol. 2013;87(9):5219&#x2010;5228. 10.1128/JVI.02643-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02643-12</ArticleId><ArticleId IdType="pmc">PMC3624296</ArticleId><ArticleId IdType="pubmed">23449802</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieman M, Yount B, Heise M, Kopecky&#x2010;Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol. 2007;81(18):9812&#x2010;9824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045396</ArticleId><ArticleId IdType="pubmed">17596301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll&#x2010;like receptor 3. J Virol. 2011;85(17):8811&#x2010;8818. 10.1128/JVI.00447-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>